Biotechnology News

Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas

PA Biotechnology Center to Begin $10 Million Expansion

Biotech incubator in Bucks County secures federal grant, launches major expansion project. - October 16, 2016 - Hepatitis B Foundation

Genome Engineering Market USD 4.2 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.

The global genome engineering market or genome editing market is estimated to reach USD 4.2 Billion in 2020, expanding at a CAGR of 10.9% from 2016 to 2020. - October 16, 2016 - iHealthcareAnalyst, Inc.

ORTHOReBIRTH USA Attending National Spine Meeting

ORTHOReBIRTH USA Attending National Spine Meeting

ORTHOReBIRTH USA of Georgetown, Texas, is attending the North American Spine Society meeting for 2016. The meeting starts on October 26 and ends on October 29 in Boston, Massachusetts. The premier spine meeting in North America, NASS 2016, has hundreds of companies from around the globe coming... - October 14, 2016 - ORTHOReBIRTH USA

Japanese Biologics Company Expands to Texas

Japanese Biologics Company Expands to Texas

ORTHOReBIRTH Co Ltd., a leading manufacturer of novel biologic products, announced the formation of ORTHOReBIRTH USA, previously Siena Biologics (Austin). The U.S. introduction of ORTHOReBIRTH’s products signals a new high-quality resource for doctors and patients throughout the... - October 14, 2016 - ORTHOReBIRTH USA

Milwaukee Urologist at Metropolitan Urology First to Offer New Office Based Treatment for Obstructive Prostate in Wisconsin

Milwaukee Urologist at Metropolitan Urology First to Offer New Office Based Treatment for Obstructive Prostate in Wisconsin

Metropolitan Urology Group SC in Milwaukee Wisconsin is the first to offer a new, office based, less invasive treatment for an enlarged prostate. The permanent implant treats symptoms due to urinary flow obstruction in men ages 50 or older. “The new implant, called the UroLift System, is... - October 13, 2016 - Metropolitan Urology Group SC

Power, Precision and Quality: Omni Introduces the GLH 850 General Laboratory Homogenizer

Omni International, Inc. announces a new product release: the GLH 850 General Laboratory Homogenizer, engineered to provide maximum accuracy and precision for medical, biological and chemical research laboratories. - October 09, 2016 - Omni International

Myths That Must be Overcome to Ensure Successful Commercialization of Biosimilars

SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016. This year’s event promises to bring even more senior experts discussing industry hot topics such as: latest approvals, biosimilar commercialization, interchangeability’s impact on biosimilars, regulatory updates and much more. - October 09, 2016 - SAE Media Group

Bioscience Americas Sponsors "Solutions for a Healthier World Foundation"

Independent not-for-profit will provide stem cell therapies for the less fortunate. - October 06, 2016 - Bioscience Americas

Living with Hepatitis B: Hepatitis B Foundation Launches Patient Storytelling Campaign

National nonprofit creates program to help people living with hepatitis B share their stories. - October 06, 2016 - Hepatitis B Foundation

Solving the Last Jigsaws to Minimize Risks, Optimize Costs and Accelerate Commercialization at Biosimilars North America

It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the US to facilitate commercialization. It is now time to meet your industry colleagues to discuss how to commercialize biosimilars, industry partnership and corporate strategy, interchangeability impact on biosimilars, regulatory updates and much more. - October 03, 2016 - SAE Media Group

RightBio Metrics to Host a Thought-Leader Forum on Improving the Safety of NG Tube Placement at NANN (National Association of Neonatal Nurses) in Palm Springs, CA

RightBio Metrics to Host a Thought-Leader Forum on Improving the Safety of NG Tube Placement at NANN (National Association of Neonatal Nurses) in Palm Springs, CA

RightBio Metrics to host a thought-leader forum on Improving the Safety of NG tube Placement at NANN (National Association of Neonatal Nurses) in Palm Springs, CA RightBioMetrics.com Considered a “never-event” in the United Kingdom (UK) and gaining increasing attention from US... - September 30, 2016 - RightBio Metrics

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN

IQ4I Research & Consultancy Published a New Report on “Genome Editing Global Market – Forecast To 2022”

Gene editing broadly refers to a suite of methods that use programmable endonuclease to target a specific site site in the genome using four major classes of gene editing technologies including meganuclease, ZFNs, TALEN and CRISPR. - September 24, 2016 - IQ4I Research & Consultancy Pvt. Ltd.

Syngene International Closes Deal with Strand Life Sciences to Purchase Systems Biology and Pharma Services Practice

Syngene International Ltd., Asia’s leading Contract Research Organization, has purchased assets of Strand Life Sciences related to systems biology, Heptox and pharma bioinformatics services. Deal boosts Syngene’s Bioinformatics and Data Analytics capabilities. - September 23, 2016 - Syngene International

Global Laboratory Information Systems Market Revenue Expected to Account for US$ 2,745.3 Mn by 2025

Implementation of Strict Laboratory Regulations by Governments to Enhance Sales of Laboratory Information Management Systems Globally. - September 22, 2016 - Market Research Hub

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader

ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO

Bioscience Americas Announces New Cellular Immunotherapy Treatment

Bioscience Americas Announces New Cellular Immunotherapy Treatment

The treatment represents a breakthrough therapy that incorporates advanced stem cell protocols. - September 20, 2016 - Bioscience Americas

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN

Lyme Disease: Designer Drugs Urgently Needed

Lyme Disease: Designer Drugs Urgently Needed

Growing epidemic outsmarts current antibiotics, says new report from ILADS and LymeDisease.org. - September 13, 2016 - USMA

Emerging Preservation Technologies and In-House Facilities to Drive Biopreservation Market to USD 4.8 Billion by 2020, Reports iHealthcareAnalyst, Inc.

According to a market research report Biopreservation Market 2013-2020, published by iHealthcareAnalyst, Inc., the global biopreservation market is estimated to reach USD 4.8 Billion in 2020, expanding at a CAGR of 9.9% from 2016 to 2020. Visit the Biopreservation Market 2013-2020 report at... - September 11, 2016 - iHealthcareAnalyst, Inc.

Agenda Released for the Highly Anticipated 6th Annual Pharmaceutical Microbiology Event: Join MHRA, Merial SAS, Pfizer, GSK, Sanofi and Many More

SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference and exhibition to Holiday Inn Kensington Forum, London on 18 - 19 January 2017. - September 09, 2016 - SAE Media Group

Chinese Pharma Rebounded to Double-Digit Growth in H1/2016 Despite Challenges

Chinese Pharma Rebounded to Double-Digit Growth in H1/2016 Despite Challenges

Core business revenues of the Chinese pharmaceutical industry grew 10.14% to CNY 1,363,565 million in the first half of 2016, according to the newly published China Pharmaceutical Guide 2016 (11th Edition) and WiCON | Pharma China (www.pharmachinaonline.com) quoting the official statistics. - September 06, 2016 - WiCON International Group LLC

Adoption of Laboratory Scale Models and Contract Research Services to Boost Cell Culture Market to USD 4.7 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global cell culture market is estimated to reach USD 4.7 Billion in 2020, growing at a CAGR of 11.7% from 2016 to 2020, according to a new market research report Cell Culture Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Cell Culture Market 2013-2020 report at... - September 06, 2016 - iHealthcareAnalyst, Inc.

ÉlpisÉremo’s Breakthrough Technology to Transcend Stem Cell Regenerative Therapy

ÉlpisÉremo succeeds in the world’s first development of a revolutionary technology comparable to the “Med-Bay” seen in the movie "Elysium." - August 26, 2016 - Elpis Eremo Inc.

PlantVax Contracted for Key Enzyme Production in Chemical Warfare Disclosure Sprays

PlantVax Contracted for Key Enzyme Production in Chemical Warfare Disclosure Sprays

PlantVax, Inc. has been contracted by a tier one US defense contractor as the primary supplier of Recombinant Human Acetylcholinesterase (AChE) in support of a Program of Record chemical warfare disclosure spray. The disclosure spray is a first-of-its-kind plant derived enzyme-based sensor that... - August 23, 2016 - Huckworthy LLC

FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke

Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Therapeutics

Contaminated Site Causing Heartburn from Acidic Conditions? A Raleigh-Based Firm Has Patented the Antacid.

Solutions-IES, Inc., (SIES) a Raleigh-based environmental engineering company, has obtained United States Patent No. 9,393,602. The invention provides a safe, low-cost, effective method for the remediation of contaminated subsurface environmental media that require increasing or maintaining pH to... - August 21, 2016 - Solutions-IES, Inc.

indee Partners with ide Group to Develop Cutting-Edge Cell Therapy Technology

ide Group is pleased to announce that it is partnering with indee to help realise a user-friendly piece of hardware for the development of simple and scalable cell therapy technologies. indee is a company founded by Ryan Pawell and Matthew Burkhardt that aims to accelerate gene therapy technology. - August 19, 2016 - IDE Group

Medical Brain Tech Company Evoke Neuroscience Ranked by Inc. 500 as One of America’s Fastest Growing Companies

Medical Brain Tech Company Evoke Neuroscience Ranked by Inc. 500 as One of America’s Fastest Growing Companies

Inc. magazine ranked Evoke Neuroscience No. 131 on its Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies. Market leader in brain assessment and training, Evoke Neuroscience made the list by achieving a three-year growth rate of 2,638%. “This recognition... - August 18, 2016 - Evoke Neuroscience

ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes

ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes

ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO

KinderPharm to Celebrate Grand Opening of New Exton Office

Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC

Academy Medical and Rennova Health, Inc. Partner to Strengthen Offering in Federally Funded Medical Facilities

Government partnership will expand access to Academy Medical’s product portfolio within the Department of Veterans Affairs (VA), Department of Defense (DoD), and Indian Health Services (IHS) for patients and clinicians. - August 15, 2016 - Academy Medical

CellectCell, Inc. Announces Georgia Research Alliance Phase IIB Funding for the Commercialization of Novel Label-Free Cell Isolation Technology

CellectCell, Inc., a company that develops novel cell isolation and purification technology, announced today the completion of milestones related to its Phase IIA grant and receipt of Phase IIB grant funding from the Georgia Research Alliance (GRA). CellectCell’s initial focus is the... - August 12, 2016 - CellectCell, Inc.

Alfa Scientific Designs Granted OTC/CLIA Waived Status for BUP Drug Test by the Food and Drug Administration

Alfa Scientific Designs Granted OTC/CLIA Waived Status for BUP Drug Test by the Food and Drug Administration

Company now has a total of 15 drug tests that are OTC/CLIA-waived. - August 11, 2016 - Alfa Scientific Designs

Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality

Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality

The Medical Technology and Practice Patterns Institute, Inc. (MTPPI) announces that it has been awarded an R01 research grant by the Agency for Healthcare Research and Quality (AHRQ). The grant will be used to investigate the impact of the End-Stage Renal Disease Prospective Payment System (ESRD PPS) reform that was enacted by Congress in 2011. - August 11, 2016 - Medical Technology and Practice Patterns Institute

Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge

Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge

Despite slowing Chinese pharma market growth to 7.6% in 2015, it remains a high growth spot with numerous emerging opportunity areas, according to the China Pharmaceutical Guide 2016 (11th Edition). Hot off the press, the China Pharmaceutical Guide 2016, an indispensable reference for MNC executives with China responsibilities for over a decade, aims to help proactive HQ and local executives feel the pulse of Chinese healthcare and stay in the driver seat of their business in the country. - August 09, 2016 - WiCON International Group LLC

Marshfield Based Preventiongenetics Earns Accreditation for Global Testing

PreventionGenetics, located in Marshfield, WI has achieved ISO 15189:2012 certification through A2LA. PreventionGenetics is a genetic testing laboratory. - August 06, 2016 - PreventionGenetics

AMTS Expands Life Science Footprint with Acquisition of Validation Specialists

AMTS Expands Life Science Footprint with Acquisition of Validation Specialists

AM Technical Solutions announces the acquisition of Boston-based, Validation Specialists and develops a more focused approach within the Life Sciences Industry. - August 04, 2016 - AM Technical Solutions

Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH

Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH

PA Biotech Center Companies Showcased to Potential Investors at Second Annual "Entrepreneur Spotlight"

Baruch S. Blumberg Institute hosts Shark Tank-style event at the Pennsylvania Biotech Center, honors Barbara Schilberg, CEO of BioAdvance. - July 29, 2016 - Hepatitis B Foundation

Eli Gilboa, University of Miami, to Present at 7th Non-Coding RNA & RNAi Therapeutics

Eli Gilboa, Professor of Microbiology & Immunology, University of Miami, to present at 7th Non-Coding RNA & RNAi Therapeutics Conference. - July 28, 2016 - GTCbio

What’s the Hype About the Gene Editing Technology CRISPR-Cas9 Without Knowing the DNA Alphabet?

“Every language is based on an Alphabet. Our DNA or genes language is no exception and is based on an Alphabet made of 64 Master DNA Sequences or 64 composite letters,” says Scientist Bob Ainuu Afamasaga. - July 28, 2016 - DNA Alphabet

Kevin Morris, from the City of Hope, to Present at 7th Non-Coding RNA & RNAi Therapeutics

Kevin Morris, City of Hope, to discuss “Genomic Dark Matter; The Complexities of Non-Coding RNA from Mechanism to Therapeutics” at Non-Coding RNA & RNAi Conference. - July 27, 2016 - GTCbio

Kepley BioSystems Selected as Finalist for 2016 Hello Tomorrow Global Startup Challenge

Kepley BioSystems Selected as Finalist for 2016 Hello Tomorrow Global Startup Challenge

Kepley BioSystems announced today that their team has been selected as a Top 500 Startup for the 2016 Hello Tomorrow Challenge. Hello Tomorrow is the world’s leading nonprofit aiming to accelerate science and technology entrepreneurship. Their mission is to catalyze the intersection of top... - July 21, 2016 - Kepley Biosystems Incorporated

Braincure Biotech Study Indicates New Target for Combating Alzheimer’s

A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech

Braincure Biotech Publishes Two New Reports

With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech

Marcus Carr, Vice President at Pfizer to Keynote at GTCbio’s Cell & Gene Therapy Conference

Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, “Clinical Development of Gene Therapy for Hemophilia B” at 3rd Cell & Gene Therapy. - July 21, 2016 - GTCbio

Bioscience Americas Outlines Growth Strategy

Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas

Hua Xu, Principal Scientist at Pfizer, to Present at Drug Design & Medicinal Chemistry Mtg

Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss “Chemical Biology Tools for Target Identification” at 11th Drug Design & Medicinal Chemistry Mtg. - July 19, 2016 - GTCbio

Press Releases 801 - 850 of 2,253